神经纤维层
视神经
医学
视神经炎
内丛状层
多发性硬化
眼科
视网膜
光学相干层析成像
神经节
外丛状层
视力
神经纤维
视网膜
神经节细胞层
病变
视神经脊髓炎
病理
解剖
神经科学
生物
精神科
作者
Rachel Nolan-Kenney,Mengling Liu,Omar Akhand,Peter A. Calabresi,Friedemann Paul,Axel Petzold,Lisanne J. Balk,Alexander U. Brandt,Elena H. Martínez‐Lapiscina,Shiv Saidha,Pablo Villoslada,Abdullah Abu Al‐Hassan,Raed Behbehani,Elliot M. Frohman,Teresa C. Frohman,Joachim Havla,Bernhard Hemmer,Hong Jiang,Benjamin Knier,Thomas Korn
摘要
Objective To determine the optimal thresholds for intereye differences in retinal nerve fiber and ganglion cell + inner plexiform layer thicknesses for identifying unilateral optic nerve lesions in multiple sclerosis. Current international diagnostic criteria for multiple sclerosis do not include the optic nerve as a lesion site despite frequent involvement. Optical coherence tomography detects retinal thinning associated with optic nerve lesions. Methods In this multicenter international study at 11 sites, optical coherence tomography was measured for patients and healthy controls as part of the International Multiple Sclerosis Visual System Consortium. High‐ and low‐contrast acuity were also collected in a subset of participants. Presence of an optic nerve lesion for this study was defined as history of acute unilateral optic neuritis. Results Among patients (n = 1,530), receiver operating characteristic curve analysis demonstrated an optimal peripapillary retinal nerve fiber layer intereye difference threshold of 5μm and ganglion cell + inner plexiform layer threshold of 4μm for identifying unilateral optic neuritis (n = 477). Greater intereye differences in acuities were associated with greater intereye retinal layer thickness differences ( p ≤ 0.001). Interpretation Intereye differences of 5μm for retinal nerve fiber layer and 4μm for macular ganglion cell + inner plexiform layer are robust thresholds for identifying unilateral optic nerve lesions. These thresholds may be useful in establishing the presence of asymptomatic and symptomatic optic nerve lesions in multiple sclerosis and could be useful in a new version of the diagnostic criteria. Our findings lend further validation for utilizing the visual system in a multiple sclerosis clinical trial setting. Ann Neurol 2019;85:618–629
科研通智能强力驱动
Strongly Powered by AbleSci AI